General Info
Location: 155 Gibbs Street
Country: United States of America
Industries: biopharmaceuticals, innovative therapies, healthcare
Investment Regions:
Investment Stages: seed
Website: http://www.bracepharma.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: The Brace Pharma Capital website news entries show the most recent investment-related announcements in 2018 (ReViral Series B on August 1, 2018; UNUM Therapeutics items in July-August 2018; Antiva Series C-1 on July 12, 2018; Precision BioSciences July 10, 2018; Miragen July 13, 2018). No investments or announcements found after 2018. The last identified portfolio investment was in ReViral (Series B, August 1, 2018). Using the provided reference material, the investor has not made known investments in well over 12 months, so classify accordingly.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Pedro …
Associate
Todd …
Director of Finance and Investments
Vinzenz …
President and CEO
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Brace Pharma Capital
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI